Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Päätekijä: | Shawn, Ibna Hasan |
---|---|
Muut tekijät: | Jamiruddin, Mohd. Raeed |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2024
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/23931 |
Samankaltaisia teoksia
-
A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
Tekijä: Chakraborty, Anupama
Julkaistu: (2024) -
Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
Tekijä: Onanna, Kazi
Julkaistu: (2024) -
Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
Tekijä: Rahman, Towsifur
Julkaistu: (2024) -
A review on combinatorial therapies in Melanoma
Tekijä: Ahmmed, Md. Kawsar
Julkaistu: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
Tekijä: Khandker, Tahia Anjum
Julkaistu: (2024)